Cargando…

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA

N6-methyladenosine (m6A) modification is the most prevalent modification in eukaryotic RNAs while accumulating studies suggest that m6A aberrant expression plays an important role in cancer. HNRNPA2B1 is a m6A reader which binds to nascent RNA and thus affects a perplexing array of RNA metabolism ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Fengjie, Tang, Xiaozhu, Tang, Chao, Hua, Zhen, Ke, Mengying, Wang, Chen, Zhao, Jiamin, Gao, Shengyao, Jurczyszyn, Artur, Janz, Siegfried, Beksac, Meral, Zhan, Fenghuang, Gu, Chunyan, Yang, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017865/ https://www.ncbi.nlm.nih.gov/pubmed/33794982 http://dx.doi.org/10.1186/s13045-021-01066-6

Ejemplares similares

Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma
por: Dou, Renjie, et al.
Publicado: (2021)

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2021)

lncRNA AK085865 Promotes Macrophage M2 Polarization in CVB3-Induced VM by Regulating ILF2-ILF3 Complex-Mediated miRNA-192 Biogenesis
por: Zhang, Yingying, et al.
Publicado: (2020)

ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease
por: Bremer, Hanna D., et al.
Publicado: (2018)

Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
por: Chen, Ying, et al.
Publicado: (2020)

Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
por: Chen, Ying, et al.
Publicado: (2021)

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2018)

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2019)

Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway
por: Sun, Danping, et al.
Publicado: (2022)

The positive feedback loop between ILF3 and lncRNA ILF3-AS1 promotes melanoma proliferation, migration, and invasion
por: Gao, Guozhen, et al.
Publicado: (2018)

Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
por: Zang, Bin, et al.
Publicado: (2021)

LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex
por: Li, Dandan, et al.
Publicado: (2022)

HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
por: Quan, Lina, et al.
Publicado: (2022)

Extramedullary disease in multiple myeloma: a systematic literature review
por: Bladé, Joan, et al.
Publicado: (2022)

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
por: Franqui-Machin, Reinaldo, et al.
Publicado: (2015)

Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
por: Jia, Chuiming, et al.
Publicado: (2023)

m(6)A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease
por: Liu, Rui, et al.
Publicado: (2022)

ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells
por: Kazuma, Yasuhiro, et al.
Publicado: (2022)

ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer
por: Li, Kai, et al.
Publicado: (2019)

RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression
por: Huang, Yanni, et al.
Publicado: (2022)

Germline Risk Contribution to Genomic Instability in Multiple Myeloma
por: Janz, Siegfried, et al.
Publicado: (2019)

Identification of an mRNA isoform switch for HNRNPA1 in breast cancers
por: Erdem, Murat, et al.
Publicado: (2021)

ILF3 contributes to the establishment of the antiviral type I interferon program
por: Watson, Samir F, et al.
Publicado: (2020)

circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA
por: Ma, Ying, et al.
Publicado: (2021)

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
por: Gu, Chunyan, et al.
Publicado: (2018)

Abnormal expression of HNRNPA3 in multistep hepatocarcinogenesis
por: Ren, Xinlu, et al.
Publicado: (2021)

Drug Targeting of Genomic Instability in Multiple Myeloma
por: Beksac, Meral, et al.
Publicado: (2020)

A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing
por: Tang, Xiaozhu, et al.
Publicado: (2022)

Inducible expression of immediate early genes is regulated through dynamic chromatin association by NF45/ILF2 and NF90/NF110/ILF3
por: Wu, Ting-Hsuan, et al.
Publicado: (2019)

Correction for: circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA
por: Ma, Ying, et al.
Publicado: (2022)

PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration
por: Zhang, Jin, et al.
Publicado: (2023)

NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer
por: Ren, Meng, et al.
Publicado: (2023)

Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
por: Charliński, Grzegorz, et al.
Publicado: (2021)

NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma
por: Wei, Rongfang, et al.
Publicado: (2022)

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
por: Yang, Ye, et al.
Publicado: (2014)

CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma
por: Han, Seong-Su, et al.
Publicado: (2015)

ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker
por: Liu, Yü, et al.
Publicado: (2019)

Compensatory expression regulation of highly homologous proteins HNRNPA1 and HNRNPA2
por: CHANG, Yan, et al.
Publicado: (2021)

WDR26 and MTF2 are therapeutic targets in multiple myeloma
por: Sun, Fumou, et al.
Publicado: (2021)

HnRNPA2B1 Aggravates Inflammation by Promoting M1 Macrophage Polarization
por: Meng, Meiyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j7pqj0t9n187gdrm49nhb4sbkq